Emerald Advisers, LLC
- SEC CIK
- 0001015083
- Latest filing
- Aug 5, 2026
SYRE holding history
Spyre Therapeutics, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRE overviewAll 13F holders of SYREFull Q2 2026 holdings
- Shares (Q2 2026)
- 567,430
- Value
- $50.4M
- % of portfolio
- 1.2%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 567,430 | $50.4M | 1.2% | −45,935−7.5% | Reduced | Holders |
| Q1 2026 | 613,365 | $30.9M | 1.0% | −22,744−3.6% | Reduced | Holders |
| Q4 2025 | 636,109 | $20.8M | 0.6% | +87,397+15.9% | Added | Holders |
| Q3 2025 | 548,712 | $9.20M | 0.3% | −17,151−3.0% | Reduced | Holders |
| Q2 2025 | 565,863 | $8.47M | 0.3% | +18,036+3.3% | Added | Holders |
| Q1 2025 | 547,827 | $8.84M | 0.4% | +1,036+0.2% | Added | Holders |
| Q4 2024 | 546,791 | $12.7M | 0.5% | +254,222+86.9% | Added | Holders |
| Q3 2024 | 292,569 | $8.60M | 0.3% | +292,569 | New | Holders |